Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Obstructive sleep apnea and fatigue in patients with multiple sclerosis.
[Central motor pathways in children with multiple sclerosis].
Balance exercise program reduced falls in people with multiple sclerosis - a single group pretest posttest trial.
Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stress.
Vitamin D-binding protein and vitamin D status of black Americans and white Americans.
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre.
Effects of multidisciplinary rehabilitation on chronic fatigue in multiple sclerosis: a randomized controlled trial.
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
Response: relationship between vitamin D and depression in multiple sclerosis.
[Natalizumab and reduction of carbonylated proteins in patients with multiple sclerosis].
Management of Spasticity in Progressive Multiple Sclerosis: Efficacy of Repeated Intrathecal Triamcinolone Acetonide Administration.
Associations of alcohol consumption with clinical and MRI measures in multiple sclerosis.
Rhythmic auditory cueing to improve walking in patients with neurological conditions other than Parkinson's disease - what is the evidence?
Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review.
Fingolimod (FTY720) stimulates ca(2+)/calcineurin signaling in fission yeast.
Association between pathological and MRI findings in multiple sclerosis.
Type 1 immune response in progressive multiple sclerosis.
Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients.
Functional role of TRP channels in modulating ER stress and Autophagy.
TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis.
Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis.
Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis.
DYNACIN (MINOCYCLINE)
Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis.
Kinin-mediated inflammation in neurodegenerative disorders.
Pages
« first
‹ previous
…
198
199
200
201
202
203
204
205
206
…
next ›
last »